{"title": "The clinical and epidemiological features and hints of 82 confirmed COVID-19 pediatric cases aged 0-16 in Wuhan, China", "doi": "10.1101/2020.03.15.20036319", "citation_id": "2020.03.15.20036319v1", "date": "2020-03-18", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.15.20036319", "abstract": "<p>Although COVID-19 pediatric patients just account for 1% of the overall cases, they are nonnegligible invisible infection sources. We quantitatively analyzed the clinical and epidemiological features of 82 confirmed cases aged 0-16 admitted to Wuhan Children9s Hospital, which are expected to shed some lights onto the pediatric diagnosis and therapy.</p>", "twitter_description": "Although COVID-19 pediatric patients just account for 1% of the overall cases, they are nonnegligible invisible infection sources. We quantitatively analyzed the clinical and epidemiological features of 82 confirmed cases aged 0-16 admitted to Wuhan Children's Hospital, which are expected to shed some lights onto the pediatric diagnosis and therapy.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis research is supported by Wuhan Scientific and Technology Bureau Project with Grant No. 2017060201010161.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nWe claim the availability of the data referred in the manuscript was approved by Wuhan Children\u0092s Hospital Ethics Committee, and official informed consent was obtained from guardians involved before enrolment when data were collected retrospectively.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.15.20036319v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.15.20036319v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.15.20036319v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/18/2020.03.15.20036319.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.15.20036319v1", "access_rights": "restricted", "authors": ["Hui Yu", "Qinzhen Cai", "Xiang Dai", "Xiuzhen Liu", "Hongs Sun"]}